Fulminant Aspergillus Pneumonitis in a Healthy Child with Chronic Granulomatous Disease
Main Article Content
Abstract
Chronic granulomatous disease (CGD) is an inherited immunodeficiency characterized as defect in one of the 4 subunits of the nicotinamide adenine dinucleotide phosphate oxidase complex affecting phagocytosis activities. Patients] symptoms are usually gradual onset or asymptomatic. The authors report a girl with rapidly progressive pneumonia in previously healthy child who not response empirical antibiotic.
Article Details
Copyright © 2024 by the Authors. Licensee Ramathibodi Medical Journal.
References
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(3):327-60. doi:10.1086/525258.
Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44(3):373-9. doi:10.1086/509917.
Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol. 2003;33(7):453-60. doi:10.1007/s00247-003-0919-4.
Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43(5):577-84. doi:10.1086/505870.
Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr. 2007;166(11):1099-117. doi:10.1007/s00431-007-0527-7.
Gupta A, McKean M, Haynes S, Wright C, Barge D, Flood TJ, et al. Chronic granulomatous disease presenting as fulminant Aspergillus pneumonitis: a lethal combination? Pediatr Crit Care Med. 2009;10(4):e43-5. doi:10.1097/PCC.0b013e318198b22a.
Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore). 1998;77(5):345-54. doi:10.1097/00005792-199809000-00004.
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155-69. doi:10.1097/00005792-200005000-00003.
Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol. 2005;43 Suppl 1:S247-59. doi:10.1080/13693780400025203.
Jirapongsananuruk O, Malech HL, Kuhns DB, Niemela JE, Brown MR, Anderson-Cohen M, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol. 2003;111(2):374-9. doi:10.1067/mai.2003.58.
Steinbach WJ. Invasive aspergillosis in pediatric patients. Curr Med Res Opin. 2010;26(7):1779-87. doi:10.1185/03007995.2010.487793.